Conclusion: Is AOD-9604 The Future Of Weight Loss
Keep sealed vials protected from light and moisture
About Our Factory & Business Background Business Type Manufacturer/Factory & Trading Company Address 9 Yugang Road, Zhengzhou Airport Economic Comprehensive Experimental Zone, Zhengzhou Plant Area 16325.83 square meters Number of Employees 360 Registered Capital 105,555,556 RMB Terms of Payment LC, T/T, D/P, PayPal, Western Union, Small-amount payment International Commercial Terms(Incoterms) FOB, CIF, CFR, EXW Average Lead Time Peak Season Lead Time: one month Off Season Lead Time: one month Nearest Port Shanghai Port, Qingdao Port Our Production Capability & Technical Expertise Main Products Veterinary Medicine, Feed Additives, Veterinary Drug Production Machines Mix Facility, Extraction Facility ODM Service Available Yes OEM Service Available Yes R&D Engineers 20 people Own Brand Yes Our Industry Experience & Global Business Record Year of Establishment 2004-06-18 Export Year 2016-02-01 Main Markets North America, South America, Europe, Southeast Asia/ Mideast, Africa, East Asia(Japan/ South Korea), Australia, Domestic Number of Foreign Trading Staff 6 Overseas Agent/Branch No FAQ What are the main indications for this injection
Peptide Vials (BPC-157 + TB-500 20 mg Blend): 4 weeks (28 doses at ~0.671.0 mg/day): 2 vials 6 weeks (42 doses): 3 vials 8 weeks (56 doses): 34 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 4 weeks: 28 syringes 6 weeks: 42 syringes 8 weeks: 56 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Conflicts of interest Both authors declare that there is no conflict of interest
